Influence of Prior Abiraterone on Clinical Activity of Docetaxel in Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer
Eur Urol 2014 Oct 01;66(4)646-652, MT Schweizer, XC Zhou, H Wang, S Bassi, MA Carducci, MA Eisenberger, ES AntonarakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.